Health

Chromatin Bioscience signe un accord de collaboration avec Astellas
Chromatin Bioscience Signs Collaboration Agreement with Astellas
Invitation to Annual General Meeting 2025
MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
AMDI Launches Autolab™ HBH at ESCMID 2025, Redefining Sample Prep for Molecular Diagnostics
Skin cancer patients could join vaccine project
MGI Tech Celebrates 10 Years of DNBSEQ™ Technology: Driving Genomics Forward with Speed, Scale, and Accessibility
CMEF Shanghai 2025 Wraps Up in Shanghai with Record-Breaking Innovations and Global Participation
Fangzhou Presents AI-Driven Healthcare Ecosystem at Guangzhou Biotech Innovation Salon
Taiwan's ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
Lab-grown human teeth to 'fill in the gaps' in regenerative dentistry
Fruitful translation of HKBU's innovative research projects takes centre stage at International Exhibition of Inventions Geneva
Alcohol Justice condena la devastación causada por la eliminación de fondos federales para la prevención del alcoholismo
Three million child deaths linked to drug resistance, study shows
Une étude majeure révèle que plus de 3 millions d'enfants sont morts d'infections liées à la résistance aux antimicrobiens en 2022
Más de 3 millones de niños murieron por infecciones relacionadas con la RAM en 2022
Over 3 million children died from AMR-related infections in 2022, major study shows
Mehr als 3 Millionen Kinder starben im Jahr 2022 an AMR-bedingten Infektionen, zeigt eine große Studie
Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal